Nu-Med Plus, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUMD research report →
Price Chart
About the company
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration.
- CEO
- William R. Colvin
- IPO
- 2014
- Employees
- 2
- HQ
- Port Jefferson, NY, US
Get TickerSpark's AI analysis on NUMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.22M
- P/E
- -48.67
- PEG
- -1.22
- P/S
- 0.00
- P/B
- -4.56
- EV/EBITDA
- -24.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 7.67%
- ROIC
- 38.31%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-48,955
- Net Income
- $-56,182+17.8%
- EPS
- $-0.00+12.5%
- OCF Growth
- -982.3%
- FCF Growth
- -982.3%
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- -2.11
- RSI (14)
- 18
- Avg Volume
- 9.30K
No earnings-call transcripts are available for NUMD yet.
- Free Float
- 55.0%
- Shares Outstanding
- 83.55M
- Float Shares
- 45.92M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 8, 26 | TEJADA FRED | other | 16,381,250 |
| Jul 8, 26 | TEJADA FRED | other | 1,000,000 |
| Jul 8, 26 | TEJADA FRED | other | 129,782 |
| Jul 7, 26 | TEJADA FRED | other | 0 |
| Aug 1, 15 | MERRELL KEITH L | other | 0 |
| Nov 7, 23 | Robins Jeffrey Lynn | other | 200,000 |
| Nov 7, 23 | HAYDE WILLIAM C | other | 1,000,000 |
| Sep 12, 22 | HAYDE WILLIAM C | other | 0 |
| Mar 2, 21 | Smith Wendy P. | other | 0 |
| Mar 2, 21 | Smith Wendy P. | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NUMD coverage
Recent articles, reports, and earnings notes.
No research on NUMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NUMD report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.